4//SEC Filing
WALSH CHRISTOPHER T PHD 4
Accession 0001181431-08-040745
CIK 0001110206other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:05 PM ET
Size
29.1 KB
Accession
0001181431-08-040745
Insider Transaction Report
Form 4
WALSH CHRISTOPHER T PHD
Director
Transactions
- Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−14,000→ 0 totalExercise: $1.58Exp: 2018-05-23→ Common Stock (14,000 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−7,000→ 0 totalExercise: $8.85Exp: 2012-05-24→ Common Stock (7,000 underlying) - Disposition from Tender
Common Stock
2008-06-26−60,000→ 0 total - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−20,000→ 0 totalExercise: $7.75Exp: 2011-04-06→ Common Stock (20,000 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−3,750→ 0 totalExercise: $9.70Exp: 2011-06-01→ Common Stock (3,750 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−9,000→ 0 totalExercise: $6.99Exp: 2013-05-23→ Common Stock (9,000 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−15,000→ 0 totalExercise: $1.00Exp: 2010-03-14→ Common Stock (15,000 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−7,500→ 0 totalExercise: $14.00Exp: 2010-10-05→ Common Stock (7,500 underlying) - Disposition to Issuer
Non-Statutory Stock Option (right to buy)
2008-06-26−8,000→ 0 totalExercise: $11.28Exp: 2014-05-27→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]Each share of Common Stock disposed of pursuant to Agreement and Plan of Merger, dated as of May 28, 2008, among the Issuer, Bristol-Myers Squibb Company and KB Acquisition Corp. (the "Merger Agreement") in exchange for $5.50 per share in cash.
- [F2]Option disposed of pursuant to Merger Agreement in exchange for an amount in cash equal to (A) the excess, if any of (1) $5.50 over (2) the exercise price per share of Issuer Common Stock subject to such option, multiplied by (B) the number of shares of Issuer Common Stock subject to such option immediately prior to the effective time of the merger (whether vested or unvested).
- [F3]On May 28, 2008, each of the members of the Board of Directors (the "Board") of the Issuer agreed to cancel the stock options originally granted to such members of the Board on May 23, 2008, which such cancellation was effective upon the closing of the tender offer contemplated by that certain Merger Agreement. No consideration was paid to the members of the Board in connection with such agreements to cancel and the related cancellations.
Documents
Issuer
KOSAN BIOSCIENCES INC
CIK 0001110206
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001120360
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:05 PM ET
- Size
- 29.1 KB